RENB RENOVARO INC Company Mergers 8-K Filing 2025 - Acquisition Agreement Renovaro Inc. has entered into a binding letter of intent to acquire Predictive Oncology Inc. in exchange for preferred stock, with terms including a 1:1 exchange ratio and a redemption price of $3.00 per share after 18 months, subject to certain conditions and approvals.Get access to all SEC 8-K filings of the RENOVARO INC